(July 1, 2003 - present) |
| QUOTED FROM UCLA HEALTH SCIENCES MEDIA REPORTS AND OTHER SOURCES (Website links to media stories are often short-lived. We have tried to remove all links that no longer function): |
Canadian Radio Addresses Sleep Apnea’s Link to Memory Loss Ronald Harper, distinguished professor of neurobiology, discussed his research linking sleep apnea to memory loss on the syndicated radio show “Sunday House Call.” It aired Aug. 3 on Canada’s CFRA 580AM. “Sunday House Call – Ron Harper, Parts 1 and 2” |
Discover Investigates Theory about how Brain Tracks Time |
Trade Reports Sleep Apnea’s Link to Memory Loss A UCLA study linking sleep apnea to memory loss was covered July 14 by the professional publication Advance for Speech-Language Pathologists and Audiologists. The journal Neuroscience Letters published the research, which was led by UCLA neurobiologists Ronald Harper and Rajesh Kumar. “Common Sleep Disorder Linked to Memory Loss” |
The Philadelphia Inquirer reported July 6 and the news service of the bilingual newspaper chain Eastern Group Publications reported July 3 on a new UCLA mouse study by neurobiologists Dr. Alcino Silva and Dan Ehninger. Their lab discovered that a drug used to prevent tissue rejection in organ-transplant patients may reverse mental impairment caused by a genetic disorder linked to autism. Human clinical trials are taking place in the
“Repair for Mental Impairment?”
“Drug may Reverse Mental Retardation Caused by Disorder”
|
Sleep Apnea’s Link to Memory Loss Draws Wide Coverage
CBS NewsPath distributed a report on a new study by Dr. Ronald Harper, distinguished professor of neurobiology, and Rajesh Kumar, assistant researcher in neurobiology, linking sleep apnea to brain injury that causes memory loss. The segment aired locally June 18 on KCAL-Channel 9, as well as 65 other CBS-affiliates across the country. The findings were also reported June 17 by the Dallas-Fort Worth ABC-affiliate’s program, “Good Morning, Texas” and The Oklahoman; June 14 by Times of India, MedHeadlines and ITwire.com; June 13 by Ivanhoe Medical Breakthroughs, Medscape and All Headline News. Additional coverage included reports in the Brazilian weekly magazine Istoe and
“Sleep Apnea Memory Loss Blamed On Brain Shrinkage”
“Common Sleep Disorder Damages Memory
“Sleep Apnea Affects Brain Tissue, Impairs Memory”
|
Sleep Disorder’s Link to Memory Loss Garners Wide Coverage
A new study by Ronald Harper, distinguished professor of neurobiology, and Rajesh Kumar, assistant researcher in neurobiology, at the David Geffen School of Medicine at UCLA, linking sleep apnea to memory loss, was reported June 11 in a front-page Los Angeles Daily News story, as well as coverage by the New York Times, U.S. News & World Report, HealthDay News, United Press International, Asian News International, PsychCentral, KFWB 980AM and Health.com. KCBS-Channel 2, KNBC-Channel 4, KABC-Channel 7 and KCAL-Channel 9 aired the findings, as well as 68 other TV markets nationwide. The HealthDay report appeared on the websites for the Washington Post,
“Common Sleep Problem Linked With Memory Loss”
“Sleep Apnea Linked to Memory Loss”
“Sleep Apnea Can Seriously Injure Brain”
|
Prevention of Blindness in Infants “Gene Therapy Improves Sight of Four Patients”
http://sciencenow.sciencemag.org/cgi/content/short/2008/428/2
|
A Nature Medicine study by Dr. Michael Sofroniew, professor of neurobiology at the David Geffen School of Medicine, that demonstrated a new way to restore walking to mice after spinal cord injury, was reported Jan. 6 by Scientific American and
"Walk Soft: Nerve Rewiring Restores most Movement Post–spinal Injury" "Scientists Move toward Helping Paralysis Patients"
“Paralysis could be Treated by Nerve Rewiring”
“Brain Says to Spine 'Heal Thyself': study”
|
Dr. Jerome Engel Jr., director of the
"Surgery to Cure Epilepsy Still Underused, but Rising"
|
Nature Focuses on New Models for Psychiatric Research
The schizophrenia research of Dr. Alcino Silva, professor of neurobiology and psychiatry at the David Geffen School of Medicine and a member of the UCLA Brain Research Institute, was featured in an Oct. 31 article in Nature News on how better mouse models for human psychiatric disorders will play a vital role in developing new treatments. He was quoted.
“Model Behaviour”
|
USA Today, Scientific American Scrutinize Dangers of Inhaling Straight Oxygen
USA Today and Scientific American published May 22 articles on a new UCLA study finding that the administration of pure oxygen, common in a medical emergency, may pose dangerous side effects by prompting brain activity that interferes with the heart's ability to function. The researchers advise medical personnel to add carbon dioxide to the inhaled oxygen to prevent permanent damage. Coauthors Ronald Harper, distinguished professor of neurobiology at the David Geffen School of Medicine; and Paul Macey, assistant researcher in neurobiology, were quoted. CBC (Canada) Radio and online news outlets Earth Times and MedGadget ran May 23 reports, and Fire Fighting News and New Kerala (India) covered the findings May 22.
“Pure Oxygen May Be Too Rich for Young Brains”
"Oxygen Meant to Resuscitate May Damage Brain"
|
How Brain Stores Memories Explored by Scientific American, Newswires
http://sciam.com/article.cfm?articleid=0BF4BCC9-E7F2-99DF-3FBDF4769A628403
http://www.thestar.com/News/article/205093
|
Newsweek, Scientific American Explore New Theory on How Brain Tells Time
The Feb. 12 issue of Newsweek and Feb. 5 Scientific American published stories on a new UCLA study revealing how the brain tells time. Dean Buonomano, associate professor of neurobiology and psychiatry at the David Geffen School of Medicine and a member of the UCLA Brain Research Institute, led the research. Health Day News also published a Feb. 2 report, which appeared on the Web sites for the Washington Post, CBC News (Canada) and Forbes, among others.
"Science: The Time is All in Your Mind"
"At Split-Second Intervals, Brain has Sense of History"
"Science Tracks How the Brain's 'Clock' Ticks"
|
Discovery of How the Brain Tells Time Garners Wide Coverage
The Feb. 1 editions of Science Magazine, Newsday, NewScientist.com and United Press International reported on a study by Dean Buonomano, associate professor of neurobiology and psychiatry at the David Geffen School of Medicine and a member of the UCLA Brain Research Institute, that proposes a new theory for how the brain tells time. Published in the Feb. 1 edition of Neuron, his findings challenge the current theory that our brains possess an inner clock. The Jan. 31 edition of In the News (UK) also covered the story.
“Brain’s Clock Has Millisecond Hand”
“Brain Doesn’t Miss Beat”
“How Long is a Split-second? It
|
Dr. Jerome Engel Jr., director of the
“The Importance of Accuracy in the Epilepsy Message”
|
Dr. Jack Feldman, distinguished professor of neurobiology, commented Jan. 30 in Technology Review on the 2006 federal budget, which cuts funding to the National Institutes of Health for the first time since 1970.
"Biomedical Funding in Crisis"
|
“Keeping Your Baby Safe from SIDS”
“Understanding Why Some Babies Don’t Gasp”
|
Reader’s Digest Highlights Statins’ Effect on Genetic Cause of Learning Disabilities
“The Truth about Statins”
|
The Dec. 11
“Researchers See Link between Parkinson’s, Toxins”
|
UCLA’s role as a national Parkinson’s research center was cited in a Nov. 27 Los Angeles Times article about a possible link between environmental toxins and the disease. UCLA’s national research program was founded in 2001 with $20 million in federal support. Dr. Marie-Francoise Chesselet, professor and chair of neurobiology and director of the
“Hot on Parkinson’s Trail”
|
New Scientist Praises Latest UCLA Statins Research |
Dr. Ronald Harper, Distinguished Professor of Neurobiology, was quoted Nov. 21 in the Los Angeles Times, Nov. 19 in the Boston Globe and Nov. 18 in the
“A Nightmare for Your Body” “Sleep Apnea Can be Dangerous” “Snoring Not Just a Nuisance; It's a Danger Sign”
|
Nature, Newsday,
UCLA scientists’ discovery that statins, a popular class of cholesterol drugs, reverses the most common genetic cause of learning disabilities in mice, captured featured stories on Nov. 9 by Newsday,
“Cholesterol Drug May Also Help Learning Disabilities”
“Common Drug Cures Learning Disability”
“Cholesterol Drug also Helps Memory”
“Statins Aid Slow Learners”
|
Health Radio Health Network Spotlights Epilepsy Treatment
Dr. Jerome Engel, professor of neurology and neurobiology and director of the
|
Newsweek Explores Connection between Depression and Heart Failure
The Oct. 3 issue of Newsweek published a story on the relationship between the heart and mind which featured brain scans from a study of UCLA heart-failure patients. The article also cited the UCLA study, which revealed a brain injury linked to depression in heart-failure patients. Coauthors Mary Woo, associate dean of the
“A Heart, Up Close”
|
Parade Magazine Reports on Surgery and Epilepsy “Their Best Chance for a
|
Science Today Highlights Stuttering Study
Dr. Ron Harper, distinguished professor of neurobiology, and his research linking sleep apnea to stuttering, was featured by the
“A Discovery Links Sleep Apnea to a Speech Impediment”
http://www.ucop.edu/sciencetoday/pages/archive/transcripts/2005/sci906.html#D
|
Business Week Reports on Heart Depression Study |
NBC News Channel, Health Day Explore Link between Heart Failure and Brain Damage
The NBC News Channel, United Press International, KFI 640 AM and
“Brain Damage Is Linked to Heart Failure”
“Heart Failure Patients Show Depression-Linked Brain Injury”
|
Science News Covers Nighttime Death Study
The Aug. 13 issue of Science News magazine highlighted research led by Dr. Jack Feldman, distinguished professor of neurobiology, and Dr. Leanne McKay, postdoctoral fellow in neurobiology, linking the cumulative loss of cells in the brain's breathing center to sleep-disordered breathing and eventual nighttime death by otherwise healthy elderly people.
“A Slumber Not So Sweet”
|
Medical Post Describes Research on Genetic Breathing Disorder
The (
“Born into Brain Damage”
|
Study on Sleep Apnea and Nighttime Dying Draws International Coverage
The Washington Post, BBC News (U.K.) and Reuters (U.S., U.K. and Indian editions) were among the international and national press that ran Aug. 8 stories on research led by Dr. Jack Feldman, distinguished professor of neurobiology, and Dr. Leanne McKay, postdoctoral fellow in neurobiology, linking the cumulative loss of cells in the brain's breathing center to sleep-disordered breathing and eventual nighttime death by otherwise healthy elderly people. The findings were also reported Aug. 10 by The Australian, Economic Times (India), Netscape News, Consumer Affairs and Taiwan News; Aug. 9 by The (London) Times, Ivanhoe Newswire, Health Central Newswire, the Pakistan Tribune, International News Network (Pakistan), The Irish Independent, Irish Health, All Headline News (DC), Macon (GA) Area Online, Best Syndication (CA), News-Medical Net (World), Health 24 (South Africa) and Red Nova (TX); Aug. 8 by United Press International, NBC News Channel, CBS-Channel 2 (Chicago), MSNBC, the Seattle Post-Intelligencer, ABC Science Online (Australia), China Daily, The (Liverpool) Daily Post, Unison (Ireland), Earth Times, Daily News Central (NV), Pravda (Russia), Brisbane (Australia) News One, The (Malaysia) Star, Med India, India Daily, Medwire News (U.K.) and Medical News Today; Aug. 7 by Bloomberg News, Reuters Health, the Daily Mail (U.K.), Knoxville (TN) News Sentinel, Billings (MT) Gazette, Bremerton (Wash.) Sun, Yahoo! News and KFI-640 A.M; and Aug. 6 by Scripps-Howard News Service. ABC (
“Study Delves Into Sleep Apnea”
“Clue to Why Some Die During Sleep”
'Dying in Sleep Linked to Apnea, Experts Say” (Reuters)
“Loss of Cells Causes Death while Sleeping, Study Says” (Scripps Howard)
|
| Frederick Gregory Featured in Science's Nextwave: When a Harvard University summer-program director told Frederick Gregory he wouldn't be accepted to Harvard's neuroscience graduate program because of his GPA, Gregory decided to prove her wrong. http://nextwave.sciencemag.org/cgi/content/full/2005/06/02/4 |
|
Neurology Now Features UCLA Epilepsy Care and Research
The inaugural issue of the magazine Neurology Now features a young UCLA patient whose life was transformed by successfully eliminating epileptic seizures, in her case through surgery. Dr. Jerome Engel, professor of neurology and neurobiology, chief of epilepsy and clinical neurophysiology and director of the
“Surgery May Stop the Seizures if the Drugs Don’t”
|
| Bloomberg News, Scientific American among Media Reporting on Alcohol Gene New research identifying how a naturally occurring gene mutation in rats’ brains dramatically lowers their tolerance to alcohol was covered Feb. 6 by Bloomberg News, and Feb. 7 by Scientific American, The (London) Daily Telegraph and Better Humans. Richard Olsen, professor of molecular and medical pharmacology, was quoted. Tom Otis, associate professor of neurobiology, was also interviewed live on CNN on Feb. 6 about the discovery, which may lead to new drugs for treating alcohol addiction in humans. Medical News Today (U.K.), People’s Daily Online (China), Xinhau (China), Calcutta Telegraph, Hindustan Times (India), New Kerala (India), Webindia123 (India), Phys.org and I-Newsire.com also covered the findings. “Mutation Makes Rats More Sensitive to Alcohol's Effects” http://www.scientificamerican.com/article.cfm?chanID=sa003&articleID=000BC1C0-DC0A-1203-9C0A83414B7F0000 “Weakness for drink could be in the genes” http://news.telegraph.co.uk/news/main.jhtml?xml=/news/2005/02/07/wdrink07.xml “US scientists find how alcohol causes brain intoxication” http://english.people.com.cn/200502/07/eng20050207_173261.html (People’s Daily Online - China) “Light Drinker Gene Located” http://www.betterhumans.com/News/news.aspx?articleID=2005-02-07-1 “Blame the gene, not the drunk” http://www.telegraphindia.com/1050208/asp/atleisure/story_4351768.asp# |
| Phoenix TV News Features UCLA-led Epilepsy Clinical Trial Two Phoenix TV news programs reported on the Early Randomized Surgical Epilepsy Trial, a multi-site clinical trial comparing the results of medication vs. surgery in the early treatment of epilepsy. Dr. Jerome Engel Jr., professor of neurology and neurobiology and director of the UCLA Seizure Disorder Center, is director of the UCLA site. The KPNX-NBC morning show aired a story on Dec. 10. KNXV-ABC aired an evening news segment on Dec. 20. “Epilepsy Clinical Trial Information” |
| Associated Press, Oregon Paper Profile Epilepsy Surgery Patient The Oct. 9 Eugene (OR) Register Guard published a story about a UCLA epilepsy surgery patient who qualified for her first driver's license at age 45 following successful surgery at UCLA. The Associated Press distributed a condensed version of the article to clients on Oct. 10. Dr. Itzhak Fried, Professor of Neurosurgery and Psychiatry and Biobehavioral Sciences, and Sandra Dewar, a clinical nurse in the Department of Neurology, were quoted. The Guard article also cited the multi-site epilepsy clinical trial led by Dr. Jerome Engel, Professor of Neurology and Neurobiology, and Director of the UCLA Seizure Disorder Center. "Life Takes Deserved Turn for Better" "Woman Earns Driver's License After Surgery Cures Epilepsy" (AP) |
| Wall Street Journal Highlights UCLA SIDS Research The Wall Street Journal published a July 20, 2004 article featuring research by Ronald Harper, UCLA Professor of Neurobiology. He images babies' brains to identify which areas may cause sudden infant death syndrome (SIDS) due to the region's inability to respond to blood pressure changes. "Latest Research on Sudden Infant Deaths Puts a Spotlight on the Role of Genes" |
| UCLA-led Clinical Trial on Epilepsy Featured on "Talk of the City" Dr. Jerome Engel Jr., Professor of Neurology and Neurobiology and Director of the UCLA Seizure Disorder Center, appeared June 2, 2004 on the KPCC FM89.3 show "Talk of the City" to discuss the treatment of epilepsy and the 19-site, National Institutes of Health-funded Early Randomized Surgical Epilepsy Trial he is directing. |
Discovery of Brain's Memory Bank Attracts International Coverage |
| UPI, Health Day Report Changes in Epilepsy Treatment Guidelines United Press International reported a speech by Dr. Jerome Engel Jr., Professor of Neurology and Neurobiology and Director of the UCLA Seizure Disorder Center, at the annual Academy of Neurology meeting in San Francisco. The April 27, 2004 article highlighted the need to break down myths surrounding the treatment of epilepsy. Engel also was quoted April 27 by HealthDay in a story about new guidelines announced at the same meeting for epilepsy treatment. The HealthDay article and a press release on the guidelines with Engel's comments received wide play on the Web, including the Washington Times, HeathCentral, Medical News Today (UK), Innovations Report (Germany) and the web sites of dozens of television affiliates. "Epilepsy Myths Must Be Exploded" (UPI) http://washingtontimes.com/upi-breaking/20040427-053912-5882r.htm "Doctors Issue New Guidelines to Treat Epilepsy" (Health Day) http://www.lex18.com/Global/story.asp?S=1820619 |
| CBS Early Show Features Epilepsy Surgery Patient The March 31, 2004 broadcast of the CBS Early Show featured UCLA epilepsy patient Chelsea Henrie and Dr. Jerome Engel Jr., Professor of Neurology and Neurobiology. When Chelsea developed epilepsy at age 16, she and her family feared she would never be able to live a normal life. The disease affected her education, social life and ability to be independent. Since surgery at UCLA two years ago by Dr. Itzhak Fried, Professor in Residence of Neurosurgery, she is now seizure free, attending college, living on her own and enjoying a full, active life. "Surgery for Epilepsy" http://www.cbsnews.com/stories/2004/03/29/earlyshow/health/main609223.shtml |
Epilepsy Patients, Clinical Trial Featured on Oregon TV and UCTV KVAL-TV (Eugene, OR) featured the story of a Springfield, OR, woman with epilepsy who is seizure-free after nearly 40 years following surgery at UCLA Medical Center. The report also mentioned the UCLA-led Early Randomized Surgical Epilepsy Trial (ERSET), which is examining whether surgery or medication is the most effective treatment early in the course of the disease. UCTV also began airing a segment on the clinical trial this week, featuring Dr. Jerome Engel Jr, Professor of Neurology and Neurobiology and principal investigator of the 19-site, $30 million clinical trial. “New Epileptic Surgery” |
Central Coast TV Outlet Reports on Epilepsy Study KCOY-TV (Santa Maria, CA) aired a January 2004 report on the Early Randomized Surgical Epilepsy Trial, a 19-site clinical trial led by Dr. Jerome Engel, Professor of Neurology and Neurobiology, which compares the success of surgery with medication in the early treatment of epilepsy. |
L.A. Times Features Spinal Cord Rehab Research |
| Syndicated Boston Globe Columnist Features Epilepsy Study Judy Foreman's "Health Sense" column in the Dec. 16, 2003 Boston Globe features a 19-site clinical trial led by Dr. Jerome Engel, Professor of Neurology and Neurobiology, that is examining the early treatment of epilepsy with surgery vs. medication. Dr. John Stern, Assistant Clinical Professor of Neurology, and UCLA patient Chelsea Henrie are quoted: "Some Epilepsy Specialists See Surgery as First Option." |
UC's Science Today, CBS Radio Network Airs Interview with UCLA Neurobiologist The University of California's Science Today radio program aired a story the week of Nov. 4, 2003 with Dr. Ron Harper, Professor of Neurobiology, on his research linking childhood stuttering to adult sleep apnea. The program airs on the CBS Radio Network, including local KNX1070 AM: “Will Children Who Stutter Have Sleep Apnea Later in Life?” http://www.ucop.edu/sciencetoday/pages/archive/transcripts/2003/sci810.html#C |
Japanese Newspaper Highlights New Journal The Hokkoku (Japan) Newspaper reported Oct. 29, 2003 that Edwin Cooper, Professor of Neurobiology, was named founding editor-in-chief of the new international journal eCam (Evidence-based Complementary and Alternative Medicine). Published by Oxford University Press, the peer-reviewed journal will document the biological mechanisms and health outcomes of complementary and alternative medicine, including traditional Asian healing practices |
L.A. Daily News Features Epilepsy Surgery Clinical TrialThe Los Angeles Daily News published a "U" section cover story on epilepsy surgery and the Early Randomized Surgical Epilepsy Trial (ERSET), a $30 million National Institutes of Health clinical trial comparing surgery vs. medication in the early treatment of the disorder. Dr. Jerome Engel Jr., Professor of Neurology [and Neurobiology], lead investigator for the trial, and Dr. Itzhak Fried, Professor in Residence of Neurosurgery, are quoted: "A New Beginning: Brain Surgery Gives Hope to Sufferers of a Common Form of Epilepsy." |
Newsday Features UCLA Experts on Genetic AnomaliesAn article in the Oct. 14, 2003 Newsday about genetic anomalies features quotes from Dr. Carmine Clemente, UCLA Professor Emeritus of Neurobiology, and Robert Trelease, UCLA Associate Adjunct Professor of Pathology and Laboratory Medicine: “Lonely Heart? No, But Her Kidney Is.” |
Ivanhoe, Riverside Press Enterprise Cover Epilepsy Surgery Study Ivanhoe “Medical Breakthroughs” distributed a news segment to television clients Oct. 1, 2003on the Early Randomized Surgical Epilepsy Clinical Trial (ERSET) led by Dr. Jerome Engel Jr., Professor of Neurology [and Neurobiology] and principal investigator for the $30 million National Institutes of Health clinical trial. The trial is examining the effectiveness of surgery vs. medication in the early treatment of epilepsy. Dr. Engel is quoted. The Ivanhoe segment aired on KPRC-TV (Houston, Texas) and Oct. 5 on News 8 Austin (Texas). The Riverside Press Telegram published an article on the trial on Oct. 7: “Treating Epilepsy” “Clinical Trial Seeks Epilepsy Patients” “Epilepsy Surgery May Not Be Last Resort” “Treating Epilepsy” |
Sacramento TV Features Epilepsy Surgical TrialKXTV-ABC (Sacramento) aired a feature on the 19-site Early Randomized Surgical Epilepsy Trial (ERSET) led by Jerome Engel Jr., a Professor of Neurology and Neurobiology at the David Geffen School of Medicine at UCLA and principal investigator. The trial will enroll 200 patients, age 12 and older, with mesial temporal lobe epilepsy, the most common form of the disorder. They will either undergo surgery or receive drug therapy. |
L.A. Times Writer Consults UCLA Anatomy Experts About Her Missing KidneyA front-page article in the Sept. 16, 2003 Los Angeles Times about people with genetic anomalies featured interviews with Dr. Carmine Clemente, Professor Emeritus of Neurobiology, and Dr. Robert Trelease, Associate Adjunct Professor of Pathology and Laboratory Medicine. The Baltimore Sun also published the story the same day: "Well, No Body's Perfect." |
Reuters News Service Spotlights Epilepsy Surgery Clinical Trial The international Reuters News Service distributed a story Sept. 3, 2003 about the Early Randomized Surgical Epilepsy Trial (ERSET) led by Dr. Jerome Engel Jr., Professor of Neurology [and Neurobiology] at UCLA. The National Institutes of Health is sponsoring the $30 million clinical trial examining the early treatment of epilepsy with surgery versus medication. Engel and Dr. Itzhak Fried, a Professor of Neurosurgery and Psychiatry, are quoted: “Epilepsy Trial Compares Brain Surgery to Drugs.” |
Dr. Ronald Harper quoted in New Scientist |
| Ventura County Star Highlights Epilepsy Patient, Clinical Trial The Ventura County Star published a feature Aug. 5, 2003 about a UCLA patient who was able to become a sport-fishing boat captain following successful epilepsy surgery. Dr. Jerome Engel, Professor of Neurology and Neurobiology, was quoted. The Star also ran a sidebar detailing the national Early Randomized Surgical Epilepsy Trial led by Engel: "Surgery Gave Man a Second Chance." "The Early Randomized Surgical Epilepsy Trial" |
| CNN, Local TV Spotlight Epilepsy Surgery Clinical Trial KABC-TV and CNN broadcast reported July 31 and July 28, 2003, respectively, on the 19-site Early Randomized Surgical Epilepsy Trial led by Dr. Jerome Engel Jr., a Professor of Neurology [and Neurobiology] and principal investigator. The trial will enroll 200 patients, age 12 and older, with mesial temporal lobe epilepsy, the most common form of the disorder. They will either undergo surgery or receive drug therapy. The CNN report also aired locally on KCAL-TV on July 29: Study to Look at Early Surgery to Treat Epilepsy." http://www.cnn.com/2003/HEALTH/conditions/07/28/epilepsy.surgery/index.html |
| Baltimore, Albany and Florida Dailies Cover Epilepsy Clinical Trial The July 20, 2003 Baltimore Sun, July 15 Albany Times Union and July 14 Florida Sun Sentinel (Fort Lauderdale) published an earlier Los Angeles Times article that featured a 19-site Early Randomized Surgical Epilepsy Trial led by Dr. Jerome Engel, a Professor of Neurology and Neurobiology and principal investigator for the study. The trial will enroll 200 patients, age 12 and older, with mesial temporal lobe epilepsy, the most common form of the disorder. They will either undergo surgery or receive drug therapy: "Treating Epilepsy: Is the Pill or the Knife Better?" (Baltimore Sun link no longer active) "Epilepsy Experts to Test Value of Surgery" (Baltimore Sun link no longer active) |
| City News Service Spotlights Epilepsy Treatment Study City News Service distributed an article July 8, 2003 about the 19-site Early Randomized Surgical Epilepsy Trial led by Dr. Jerome Engel Jr., a Professor of Neurology and Neurobiology at the David Geffen School of Medicine at UCLA and principal investigator. News of the study also was included in the Health Care Advisory Board's June 30 news briefing. The trial will enroll 200 patients, age 12 and up, with mesial temporal lobe epilepsy, the most common form of the disorder. They will either undergo surgery or receive drug therapy. |
| Los Angeles Times Features UCLA-led Epilepsy Treatment Clinical Trial The Los Angeles Times' "In the Lab" column in the June 30, 2003 Health section featured the 19-site Early Randomized Surgical Epilepsy Trial led by Dr. Jerome Engel, principal investigator and Professor of Neurology and Neurobiology. The trial will enroll 200 patients, age 12 and older, with mesial temporal lobe epilepsy, the most common form of the disorder. They will undergo surgery or receive drug therapy: "Epilepsy Surgery: Sooner or Later?" |